The increasing prevalence of cardiovascular diseases and the rising demand for minimally invasive procedures are significant growth drivers for the drug-eluting balloon catheters market. Additionally, advancements in technology leading to improved drug-eluting balloon catheter designs and growing awareness about the benefits of these devices are contributing to market growth.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Product, Raw Material, End-Use |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Medtronic, Aachen Resonance, B Braun Melsungen AG, BD Interventional, Biosensors International, Biotronik AG, Boston Scientific, Eurocor, iVascular S L U, Zhejiang Barty Medical Technology Co, Lepu Medical TechnologyCo, MedAlliance |
The high costs associated with drug-eluting balloon catheter procedures and the stringent regulatory requirements for their approval are major restraints in the market. These factors pose challenges for market players in terms of market penetration and profitability.